Together with our recent identification of GOLPH3 as a radiosensitization target in lung cancer [27], the inhibition of GOLPH3 in radiotherapy appears to kill these “two birds” with one stone, so targeting GOLPH3 may be a promising strategy to achieve therapeutic benefit in radiotherapy. This evidence concerns the gene GOLPH3 and lung carcinoma.